Alok Kumar Sinha, MD in Johnson City, TN - Medicare Student in an Organized Health Care Education/Training Program

Alok Kumar Sinha, MD is a medicare enrolled "Student In An Organized Health Care Education/training Program" physician in Johnson City, Tennessee. His current practice location is Va Bldg 1, Johnson City, Tennessee. You can reach out to his office (for appointments etc.) via phone at (423) 439-6210.

Alok Kumar Sinha is licensed to practice in * (Not Available) (license number ) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1609439686.

Contact Information

	Alok Kumar Sinha, MD
	Va Bldg 1, Johnson City, TN 37614-6503
	(423) 439-6210
	(423) 439-8060

Physician's Profile

Full Name	Alok Kumar Sinha
Gender	Male
Speciality	Student In An Organized Health Care Education/training Program
Location	Va Bldg 1, Johnson City, Tennessee
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1609439686
Provider Enumeration Date: 04/16/2019
Last Update Date: 06/08/2023

Medicare PECOS Information:

PECOS PAC ID: 5092172593
Enrollment ID: I20230526000734

Medical Identifiers

Medical identifiers for Alok Kumar Sinha such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1609439686	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207ZP0102X	Pathology - Anatomic Pathology & Clinical Pathology	2023-00413 (North Carolina)	Secondary
390200000X	Student In An Organized Health Care Education/training Program	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Alok Kumar Sinha is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Alok Kumar Sinha, MD Po Box 70568, Johnson City, TN 37614-1707 Ph: (423) 439-6210	Alok Kumar Sinha, MD Va Bldg 1, Johnson City, TN 37614-6503 Ph: (423) 439-6210

News Archive

EC approves Vertex's KALYDECO for treatment of cystic fibrosis

Vertex Pharmaceuticals Incorporated announced today that the European Commission has approved KALYDECOTM (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Labeling calories on menus mandatory – unhealthy eating discouraged further

With the newly passed healthcare bill calorie counts at fast food and chain restaurants become mandatory. More than 200,000 fast food and other chain restaurants will have to include calorie counts on menus, menu boards, buffets, vending machines, alcoholic drink menus and even drive-throughs.

Researchers find compound 10 times more effective than isoniazid, the leading anti-tuberculosis drug

Researchers at the Albert Einstein College of Medicine of Yeshiva University have synthesized chemicals that are up to 10 times more effective than isoniazid, the leading anti-tuberculosis drug.

USPTO awards Furiex method patent for dapoxetine in treatment of premature ejaculation

Furiex Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office issued a patent on May 18, 2010, for the method for treatment of premature ejaculation using dapoxetine. Furiex developed dapoxetine in collaboration with Alza Corporation and its affiliates. U.S. Patent No. 7,718,705 includes claims directed to dosing dapoxetine on an as-needed basis, capturing the advantage dapoxetine has over other compounds in the same class, which require a pre-loading period for efficacy.

Chemotherapy increases risk for mild cognitive deficits in breast cancer patients

A large meta-analysis conducted by researchers at Moffitt Cancer Center has concluded that breast cancer patients treated with chemotherapy are at risk for mild cognitive deficits after treatment.

Alok Kumar Sinha, MD - Medicare Student in an Organized Health Care Education/Training Program in Johnson City, TN